Academia: Optimize and validate research protocols with mAb drug aliquots
“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”
Biosimilars: Reference Drug Aliquots for Faster Selection and Development of CHO-based Production Processes
“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”
Reference Drug Aliquots: The right control for Assays
“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”
Aliquots: A New Solution to the Batch Variability Problem
“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”